JP2008535831A5 - - Google Patents

Download PDF

Info

Publication number
JP2008535831A5
JP2008535831A5 JP2008504436A JP2008504436A JP2008535831A5 JP 2008535831 A5 JP2008535831 A5 JP 2008535831A5 JP 2008504436 A JP2008504436 A JP 2008504436A JP 2008504436 A JP2008504436 A JP 2008504436A JP 2008535831 A5 JP2008535831 A5 JP 2008535831A5
Authority
JP
Japan
Prior art keywords
group
alkyl
compound
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008504436A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008535831A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/012022 external-priority patent/WO2006121528A2/en
Publication of JP2008535831A publication Critical patent/JP2008535831A/ja
Publication of JP2008535831A5 publication Critical patent/JP2008535831A5/ja
Pending legal-status Critical Current

Links

JP2008504436A 2005-04-01 2006-03-31 環閉鎖および関連する方法および中間体 Pending JP2008535831A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66784005P 2005-04-01 2005-04-01
PCT/US2006/012022 WO2006121528A2 (en) 2005-04-01 2006-03-31 Ring closing and related methods and intermediates

Publications (2)

Publication Number Publication Date
JP2008535831A JP2008535831A (ja) 2008-09-04
JP2008535831A5 true JP2008535831A5 (enExample) 2009-05-21

Family

ID=37397032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008504436A Pending JP2008535831A (ja) 2005-04-01 2006-03-31 環閉鎖および関連する方法および中間体

Country Status (6)

Country Link
US (1) US8168802B2 (enExample)
EP (1) EP1863770A4 (enExample)
JP (1) JP2008535831A (enExample)
AU (1) AU2006244635A1 (enExample)
CA (1) CA2602853A1 (enExample)
WO (1) WO2006121528A2 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
WO2005018556A2 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
RU2006105101A (ru) 2003-08-27 2007-10-10 3М Инновейтив Пропертиз Компани (US) Арилокси и арилалкиленокси замещенные имидазохинолины
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AR046172A1 (es) 2003-10-03 2005-11-30 3M Innovative Properties Co Pirazolopiridinas y sus analogos; composiciones farmaceuticas que los contienen y su uso en la inhibicion de la biosintesis de citocinas
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
US8598192B2 (en) 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
WO2005066170A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006028962A2 (en) 2004-09-02 2006-03-16 3M Innovative Properties Company 1-alkoxy 1h-imidazo ring systems and methods
EP1831226B1 (en) 2004-12-30 2012-08-08 3M Innovative Properties Company Chiral tetracyclic compounds inducing interferon biosynthesis
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
AU2006212765B2 (en) 2005-02-09 2012-02-02 3M Innovative Properties Company Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
CA2597587A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
EP1850849A2 (en) 2005-02-23 2007-11-07 Coley Pharmaceutical Group, Inc. Method of preferentially inducing the biosynthesis of interferon
WO2006107853A2 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
ES2429170T3 (es) * 2005-11-04 2013-11-13 3M Innovative Properties Company 1H-Imidazoquinolinas sustituidas con hidroxilo y alcoxilo y métodos
EP1988896A4 (en) 2006-02-22 2011-07-27 3M Innovative Properties Co CONJUGATES TO MODIFY IMMUNE REACTIONS
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
DK2606047T3 (en) 2010-08-17 2017-03-27 3M Innovative Properties Co COMPOSITIONS AND FORMULATIONS WITH LIPIDIZED IMMUNE RESPONSE-MODIFIING COMPOUND AND PROCEDURES THEREOF
EP3153180A1 (en) 2011-06-03 2017-04-12 3M Innovative Properties Company Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
BR112013031028A2 (pt) 2011-06-03 2016-11-29 3M Innovative Properties Co conectores heterobifuncionais com segmentos de polietileno glicol e conjugados de modificadores de resposta imunológica feitos a partir deles
JP5935123B2 (ja) * 2011-08-22 2016-06-15 国立研究開発法人産業技術総合研究所 高温高圧クロスカップリング法
ES2538880B1 (es) * 2013-12-24 2016-09-08 Laboratorios Viñas S.A. Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
KR102685007B1 (ko) * 2015-08-31 2024-07-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 구아니딘 치환된 이미다조[4,5-c] 고리 화합물
WO2017040234A1 (en) * 2015-08-31 2017-03-09 3M Innovative Properties Company IMIDAZO[4,5-c] RING COMPOUNDS CONTAINING SUBSTITUTED GUANIDINE GROUPS
RU2722149C1 (ru) * 2015-09-14 2020-05-27 Пфайзер Инк. Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2
US10766896B2 (en) 2017-03-01 2020-09-08 3M Innovative Properties Company Imidazo[4,5-c] ring compounds containing guanidine substituted benzamide groups
CA3086439A1 (en) 2017-12-20 2019-06-27 3M Innovative Properties Company Amide substitued imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1645976A1 (de) 1966-06-18 1971-01-21 Ajinomoto Kk Verfahren zur Herstellung von Adenosin und 2',3'-O-Isopropylidenadenosin
US4420617A (en) * 1980-03-28 1983-12-13 Sterling Drug Inc. 5(Pyridinyl)pyridin-2-amines
DE3723070A1 (de) * 1987-07-11 1989-01-19 Bayer Ag Verfahren zur herstellung von substituierten pyridylalkylketonen
CA2131680C (en) * 1993-09-17 2006-11-07 Gerhard Stucky Process for preparing imidazopyridine derivatives
UA67760C2 (uk) * 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
AU2220801A (en) * 1999-12-22 2001-07-03 Kyorin Pharmaceutical Co. Ltd. Tricyclic compounds and addition salts thereof
IL150841A0 (en) * 2000-02-09 2003-02-12 Hokuriku Pharmaceutical 1h-imidazopyridine derivatives
US6677349B1 (en) * 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof

Similar Documents

Publication Publication Date Title
JP2008530099A5 (enExample)
JP2007507542A5 (enExample)
JP2009509971A5 (enExample)
JP2008503484A5 (enExample)
JP2009507036A5 (enExample)
JP2007502288A5 (enExample)
JP2007502293A5 (enExample)
JP2007512349A5 (enExample)
JP2007513170A5 (enExample)
JP2007504161A5 (enExample)
CA2540541A1 (en) Alkoxy substituted imidazoquinolines
JP2007517035A5 (enExample)
US8168802B2 (en) Ring closing and related methods and intermediates
JP2007517044A5 (enExample)
JP2007512370A5 (enExample)
JP2007530450A5 (enExample)
JP2012236838A5 (enExample)
JP2007508305A5 (enExample)
JP2008511677A5 (enExample)
JP2007511613A5 (enExample)
JP2006512301A5 (enExample)
JP2014510774A5 (enExample)
CA2536136A1 (en) Aryloxy and arylalkyleneoxy substituted imidazoquinolines
JP2002529532A5 (enExample)
JP2010539166A5 (enExample)